FIELD: biotechnologies.
SUBSTANCE: single-thread RNA is described with common formula G1XmGn or C1XmCn, which is modified with lipid. The single-thread RNA may act as immunogen, inducing the inherent immune response. The pharmaceutical composition is described. The invention may be used to treat infectitious diseases, allergies or cancer diseases.
EFFECT: improved composition properties.
22 cl, 15 dwg, 24 ex
Authors
Dates
2013-07-20—Published
2007-07-31—Filed